NCT Number,Study Title,Study URL,Study Status,Conditions,Interventions,Primary Outcome Measures,Sponsor,Collaborators,Sex,Age,Phases,Enrollment,Funder Type,Study Type,Study Design,Other IDs,Start Date,Primary Completion Date,Completion Date,First Posted,Results First Posted,Last Update Posted,Locations,Study Documents
NCT02876328,Partnership for Research on Ebola VACcinations,https://clinicaltrials.gov/study/NCT02876328,COMPLETED,Ebola Virus Disease,BIOLOGICAL: Ad26.ZEBOV|BIOLOGICAL: MVA-BN-Filo|BIOLOGICAL: rVSVΔG-ZEBOV-GP|BIOLOGICAL: Placebo|BIOLOGICAL: rVSV boost,"Percentage of Participants With Ebola Virus Glycoprotein (GP-EBOV) Antibody Response, Antibody responder at 12 months is defined as a participant who experiences a 4-fold increase in antibody level from baseline and for whom the antibody level at 12 months is greater than or equal to 200 EU/mL., Measured through Month 12",National Institute of Allergy and Infectious Diseases (NIAID),"Partnership for Research on Ebola Virus in Liberia (PREVAIL)|Institut National de la Santé Et de la Recherche Médicale, France|London School of Hygiene and Tropical Medicine|European and Developing Countries Clinical Trials Partnership (EDCTP)",ALL,"CHILD, ADULT, OLDER_ADULT",PHASE2,4789,NIH,INTERVENTIONAL,"Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: QUADRUPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: PREVENTION",C15-33|PREVACEBL3005,2017-03-27,2019-12-24,2023-12-20,2016-08-23,2022-09-28,2024-06-26,"Centre national de formation et de recherche en santé rurale (Maferyniah), Conakry, Guinea|Landreah, Conakry, Guinea|The Redemption Hospital, Monrovia, Liberia|Centre pour le Développement des Vaccins (CVD), Bamako, Mali|University Clinical Research Center (UCRC), Bamako, Mali|Mambolo Clinic, Kapesseh, Sierra Leone","Study Protocol, https://cdn.clinicaltrials.gov/large-docs/28/NCT02876328/Prot_001.pdf|Statistical Analysis Plan, https://cdn.clinicaltrials.gov/large-docs/28/NCT02876328/SAP_002.pdf|Informed Consent Form, https://cdn.clinicaltrials.gov/large-docs/28/NCT02876328/ICF_003.pdf"
